6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Hiller, Louise ; Vallier, Anne-Laure ; McAdam, Karen ; Hughes-Davies, Luke ; Ah-See, Mei-Lin ; Simcock, Richard ; Rea, Daniel ; Raj, Sanjay ; Woodings, Pamela ; Harries, Mark ; Raynes, Kerry ; Higgins, Helen B ; Plummer, Chris ; Mansi, Janine ; Mahler–Araujo, Betania ; Abraham, Jean E ; Caldas, Carlos ; McCabe, Christopher ; Miles, David ; Wardley, Andrew M ; Cameron, David A ; Agarwal, Roshan ; Algurafi, Hafiz ; Archer, Caroline ; Armstrong, Anne ; Bale, Catherine ; Barraclough, Lisa ; Barthakur, Urmila ; Bedi, Carolyn ; Benstead, Kim ; Bloomfield, David ; Bowen, Rebecca ; Bradley, Chris ; Brown, Jane ; Butt, Mohammad ; Churn, Mark ; Cleator, Susan ; Cliff, Joanne ; Crellin, Perric ; Daly, Margaret ; De Silva-Minor, Shiroma ; Dhadda, Amandeep ; Din, Omar ; Down, Sue ; Earl, Helena ; Eaton, David ; Eichholz, Andrew ; Epurescu, Daniel ; Goh, Chee ; Goodman, Andrew ; Grieve, Robert ; Hadaki, Maher ; Harper-Wynne, Catherine ; Harries, Mark ; Hayward, Larry ; Humphreys, Alison ; Innes, Helen ; Jafri, Mariam ; Jegannathen, Apurna ; Kelleher, Muireann ; Kristeleit, Hartmut ; Lee, Daniela ; Lupton, Susan ; MacGregor, Carol ; Malik, Zafar ; Mansi, Janine ; Marshall, Jennifer ; McAdam, Karen ; McGolick, Trevor ; Mehra, Rakesh ; Miles, David ; Mithal, Natasha ; Moss, Charlotte ; Moss, Aian ; Nelmes, Daniel ; Neville-Webbe, Helen ; Newby, Jacqueline ; O'Reilly, Susan ; Ostler, Peter ; Persic, Mojca ; Pettit, Laura ; Raj, Sanjay ; Raja, Fharat ; Rea, Daniel ; Reed, Catherine ; Rigg, Anne ; Roe, Helen ; Shah, Nihal ; Simmonds, Peter ; Sims, Eliot ; Smith, Sarah ; Storey, Nicola ; Taylor, Wendy ; Tipples, Karen ; Vaidya, Jayant ; Varughese, Mohini ; Walji, Nawaz ; Woodings, Pamela ; Wright, Kathryn ; Yahya, Sundus

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2599-2612 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível